This week's top media moves include Teen Vogue's new style director, CEO shifts at Converse and Wolford, and more.

Kenvue Inc. (NYSE: KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s ...

Kenvue, makers of Benadryl, introduces 'Cough Clinics' in partnership with the Association of Physicians of India. This ...

Inventiva named Jason Campagna as president of R&D and chief medical officer, and Martine Zimmermann as EVP of regulatory affairs and quality assurance. Evolent named Dr. David Lim as chief clinical ...

Kenvue Inc. closed 13.19% below its 52-week high of $25.17, which the company achieved on May 8th.

Experts are raising concerns about Benadryl’s ability to cross the blood-brain barrier and potential lasting impacts.

Kenvue Inc. has announced a leadership change and the initiation of a strategic review aimed at optimizing its brand ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...

We recently published 10 Stocks Jim Cramer Discussed As He Commented On Latest Tariffs. Kenvue Inc. (NYSE:KVUE) is one of the ...

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

U.S. stocks are drifting mostly higher following some mixed data on inflation and profits at some of the biggest U.S. banks.